Organizers: Johanna P. Daily (Albert Einstein College of Medicine), David A. Fidock (Columbia University Medical Center), Takushi Kaneko (TB Alliance), and Jennifer Henry (The New York Academy of Sciences)Presented by the Vaccine Science Discussion Group
Reported by Hema Bashyam | Posted June 8, 2012
The malaria parasite Plasmodium is estimated to have killed more humans throughout history than any other single cause. Now, more than a decade into the 21st century, it continues to be a global killer, causing more than a million deaths a year, most of them in sub-Saharan Africa. In this region, malaria claims the life of one child every minute—one of the many grim statistics cited during the Malaria 2012: Drugs, Vaccines, and Pathogenesis symposium held at the New York Academy of Sciences on April 17, 2012.
The Symposium featured talks by scientists who are developing and implementing a multi-disciplinary toolbox that includes several recently developed molecular, genetic, and chemical techniques, as well as epidemiological and "omics" approaches to investigate Plasmodium's basic biology and its interaction with human hosts and mosquito vectors. With this these tools, researchers hope to identify pressure points in the parasite's biology that could be exploited therapeutically. Also speaking at the symposium were scientists who are bridging the gap between basic, preclinical, and clinical research to improve drug design and to advance vaccine development efforts. The results of these multi-pronged efforts are, in the words of several of the speakers, justification for a sense of cautious optimism in the global drive to eradicate malaria.
Use the tabs above to find a meeting report and multimedia from this event.
Presentations available from:
Johanna Daily, MD (Albert Einstein College of Medicine)
Kirk Deitsch, PhD (Weill Cornell Medical College)
David Fidock, PhD (Columbia University Medical Center)
Manuel Llinás, PhD (Princeton University)
Victor Nussenzweig, MD, PhD (New York University Langone Medical Center)
Chris Plowe, MD, MPH (University of Maryland)
Ana Rodriguez, PhD (New York University School of Medicine)
Vern L. Schramm, PhD (Albert Einstein College of Medicine)
Timothy N.C. Wells, PhD (Medicines for Malaria Venture)
Corporate Alliance on Malaria in Africa (CAMA)